Traditional peptide formulations often suffer from poor skin absorption, resulting in active ingredients remaining on the skin surface without reaching the target skin layers.
ActiTide Bouncera, a combination of three peptides, Palmitoyl Tripeptide-5 (collagen supplement), Hexapeptide-9 (skin bonding enhancer) and Hexapeptide-11 (collagen degradation inhibitor), claims to solve the problem using supramolecular synergistic penetration technology, which includes the supramolecular ionic liquid DES-TG.
Using advanced fluorescence detection technology, the penetration properties of the individual peptides within the complex were evaluated. The study showed that ActiTide Bouncera achieved 3-5 times the penetration intensity of the control group for each peptide individually. Fluorescence imaging confirmed deep dermal targeting, ensuring that the biopeptide active ingredients reach fibroblasts and the dermal-epidermal junction (DEJ), where they can exert maximum effect.
This intelligent formulation targets the dermis, effectively smoothing collagen loss, reducing fine lines and wrinkles, increasing skin firmness, and restoring skin elasticity.
Physiochemically, ActiTide Bouncera is a colorless, clear to translucent liquid designed for optimal stability and ease of formulation. It is highly compatible with a wide range of skin care products, including high-quality serums, firming creams, and restorative masks. The recommended dosage of 0.2 to 5.0% allows for versatile use in formulations aimed at reducing deep wrinkles and structural skin rejuvenation.
